FGFR2 and cancer: Hence in order to provide further evidence and directly assess the genetic disease risk for selfish mutations in the future offspring of cancer survivors, we have exploited our ability to quantify 12 different de novo mutations at the FGFR2 c.752–755 locus (Fig. 1A).